Thiabendazole is a relatively safe and effective agent with a wide range of activity against nematodes infesting the gastrointestinal tract. A 55-yr-old man developed prolonged jaundice and sicca complex after a course of thiabendazole therapy. Endoscopic retrograde cholangiopancreatography demonstrated normal biliary tree and pancreatic ducts. Liver biopsy was consistent with a drug-induced intrahepatic cholestatic reaction. The patient recovered completely from his liver injury, but the sicca complex persisted 1 yr after the drug was given. The literature on thiabendazole-induced cholestasis and its association with sicca complex is reviewed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Accuracy of Labial Salivary Gland Biopsy in Suspected Cases of Sjogren's Syndrome.
Cureus
November 2024
Pathology and Laboratory Medicine, Salmaniya Medical Complex, Manama, BHR.
Introduction: Sjögren's syndrome (SS) is a chronic autoimmune disorder primarily characterized by dysfunction of the exocrine glands, leading to dryness of the eyes and mouth (sicca symptoms). Labial salivary gland biopsy (LSGB) is a key diagnostic tool used to confirm SS through histopathological analysis. LSGB evaluates lymphocytic infiltration in the salivary glands, a hallmark of SS.
View Article and Find Full Text PDFExploring Overlap Syndromes: An Atypical Case of Multiple Sclerosis With Anti-Sjogren's Syndrome Type B Antibody.
J Med Cases
December 2024
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.
Evaluating patients with symptoms suggestive of demyelinating disease such as multiple sclerosis (MS) is common in both the inpatient and outpatient setting but may be difficult if atypical neurological symptoms are present. In this case, a 39-year-old female presented with new onset weakness and paresthesias. The patient reported 3 weeks of progressively worsening left face and hemibody numbness, along with gait abnormality.
View Article and Find Full Text PDFExpanding clinical characteristics and genotypic profiling of Yao syndrome in Chinese patients.
Front Immunol
September 2024
Department of Rare Diseases, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences & Peking Union Medical College; State Key Laboratory of Complex Severe and Rare Diseases, PUMCH; Department of Rheumatology and Clinical Immunology, PUMCH; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Article Synopsis
- Yao syndrome (YAOS) is a systemic autoinflammatory disease with limited clinical reports in China; this study presents the largest cohort of Chinese YAOS patients to enhance knowledge about its characteristics and treatment.
- The research involved 15 adult patients diagnosed with YAOS, utilizing whole-exome sequencing to analyze clinical features, genetic variations, and treatment outcomes, comparing them with a Caucasian cohort.
- Findings revealed a mean disease onset age of 35 years, common symptoms like recurrent fever and gastrointestinal issues, and a high response rate to treatments such as glucocorticoids and TNF inhibitors, with notable differences in symptoms and demographic features compared to Caucasians.
Quintessence of currently approved and upcoming treatments for dry eye disease.
Graefes Arch Clin Exp Ophthalmol
August 2024
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Nathalal Parekh Marg, near Khalsa College, Matunga East, Mumbai, 400019, India.
Article Synopsis
- - Dry eye disease (DED) is a complex eye condition, and this review summarizes current and future treatment options for it by looking at research from PubMed, FDA, and other databases.
- - Current FDA-approved treatments for DED include several cyclosporine formulations, lifitegrast (XIIDRA), and various medical devices designed to improve tear production and treat meibomian gland dysfunction.
- - Numerous clinical trials are ongoing to evaluate new treatments for DED, including various novel drops and solutions, aiming to enhance symptomatic relief as well as overall management of the disease.
Variants in the autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
bioRxiv
October 2023
Genes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Fine mapping and bioinformatic analysis of the genetic risk association in Sjögren's Disease (SjD) and Systemic Lupus Erythematosus (SLE) identified five common SNPs with functional evidence in immune cell types: rs4938573, rs57494551, rs4938572, rs4936443, rs7117261. Functional interrogation of nuclear protein binding affinity, enhancer/promoter regulatory activity, and chromatin-chromatin interactions in immune, salivary gland epithelial, and kidney epithelial cells revealed cell type-specific allelic effects for all five SNPs that expanded regulation beyond effects on and expression. Mapping the local chromatin regulatory network revealed several additional genes of interest, including .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!